Today: 28 January 2026
Subscribe
Browse Category

NYSE:DBD News 4 January 2026

Diebold Nixdorf (DBD) stock slides nearly 6% to start 2026 — what traders watch next

Diebold Nixdorf (DBD) stock slides nearly 6% to start 2026 — what traders watch next

New York, January 4, 2026, 13:18 ET — Market closed Diebold Nixdorf shares closed down 5.79% on Friday at $63.96, marking a sharp retreat on the first trading day of 2026. The stock will reopen for trading on Monday after U.S. markets stayed shut over the weekend. Diebold Nixdorf Investors The move matters because the ATM and bank-technology provider had…
4 January 2026
·····
Diebold Nixdorf stock sinks nearly 6% to start 2026 as traders brace for jobs data

Diebold Nixdorf stock sinks nearly 6% to start 2026 as traders brace for jobs data

NEW YORK, Jan 3, 2026, 21:14 ET — Market closed Diebold Nixdorf (NYSE: DBD) shares fell $3.95, or 5.8%, to end Friday at $63.96, marking a sharp retreat on the first trading day of 2026. The drop matters because the stock had been trading near its highs after a late-December rally, and early-year positioning can magnify swings in smaller names.…
4 January 2026
·····

Stock Market Today

  • BigBear.ai (BBAI) Stock Declines Amid Revenue Drops and SEC Probe: Should Investors Sell or Hold?
    January 28, 2026, 10:32 AM EST. BigBear.ai (NYSE: BBAI) fell more than 2% on Monday amid ongoing concerns about a 20% revenue decline, accounting restatements, and an SEC securities fraud investigation. The stock has dropped over 40% from its 52-week high near $10.36. Trading volume was below average, indicating steady institutional selling rather than panic. Despite a stable semiconductor and AI sector, BBAI faced company-specific headwinds linked to shrinking U.S. Army contracts. While cash reserves exceed $456 million, investors face a dilemma: short-term traders see a downtrend below key moving averages, while long-term holders weigh risks against potential gains from AI defense contracts and a pending Ask Sage acquisition. The company's legal and financial challenges fuel debate on whether to hold or sell the stock.
Go toTop